scispace - formally typeset
I

Iain Chalmers

Researcher at University of Oxford

Publications -  328
Citations -  28623

Iain Chalmers is an academic researcher from University of Oxford. The author has contributed to research in topics: Systematic review & Health care. The author has an hindex of 67, co-authored 315 publications receiving 26323 citations. Previous affiliations of Iain Chalmers include Norwegian Institute of Public Health & Cochrane Collaboration.

Papers
More filters
Journal ArticleDOI

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

TL;DR: Empirical evidence is provided that inadequate methodological approaches in controlled trials, particularly those representing poor allocation concealment, are associated with bias.
Journal ArticleDOI

Avoidable waste in the production and reporting of research evidence

TL;DR: “Research results should be easily accessible to people who need to make decisions about their own health...
Journal ArticleDOI

How to increase value and reduce waste when research priorities are set

TL;DR: This report discusses how avoidable waste can be considered when research priorities are set and recommends ways to improve the yield from basic research, and the transparency of processes by which funders prioritise important uncertainties should be increased.
Journal ArticleDOI

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial

Haleema Shakur, +456 more
- 27 May 2017 - 
TL;DR: The effect of tranexamic acid on the risk of death from post-partum haemorrhage and hysterectomy was estimated to be low, and death due to bleeding was significantly reduced in women given tranExamic acid.
Journal ArticleDOI

Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?

TL;DR: Hilda Bastian and colleagues examine the extent to which critical summaries of clinical trials can be used by health professionals and the public.